Never-Before-Seen Abnormal Blood Clots in COVID-19 Vaccinated Patients

An excerpt from Taylor Hudak’s interview with Prof. Arne Burkhardt.

Watch the full interview here.

Written by Taylor Hudak

There are two types of clots associated with the COVID-19 injections. The first is a normal thrombotic clot, which occurs as a healing mechanism and is formed by thrombocytes and fibrin. For example, if one gets a cut on the skin, a thrombin formation begins and the endothelium regenerates. This is part of a normal healing process. 

The second type of blood clot associated with the COVID-19 injections has not been observed prior to the introduction of the mRNA injections and was first detected in the US.

“I personally have been in the United States, and I was a guest for almost one year with an undertaker (mortician), and there, I got my first experience with dead people,” said Prof. Burkhardt. “I know that from that time, nobody ever observed these casts in the vessels.” 

It is important to note that mortuary work differs in the United States and Germany. Unlike Germany, the US has a special process in which deceased individuals are embalmed. This requires a mortician, or undertaker, to open the arteries and veins of the deceased in order to inject fixation fluid into the body. 

“Soon after this vaccination campaign started, there were reports form undertakers in the US that they observed these very strange casts in the blood vessels.”

Prof. Burkhardt was most likely referring to the findings reported by embalmer Richard Hirschman, which were examined by Dr. Mike Adams. An image of the findings are shown below.

“They were long elastic structures not adherent to the walls so they are not caused by normal vascular damage — they are very extensive,” he added. “So just from the first report that I read, I was convinced this could not have been the cause of the death because if all your arteries are blocked, you would die before all this has formed.”

Additionally, he stated he was certain these clots formed post mortem, or after death, and were associated with a cooling of the body. (Prior to embalming, deceased bodies must be cooled.)

Abnormal blood clot in healthy runner

“We have been observing these phenomenon in living persons, and this is, I think, something that hasn’t been looked into before.”

In cases in which abnormal blood clots were observed in living patients, it is important to note that the clots were localized events and therefore more survivable. However, the symptoms were severe enough to impact the patients’ quality of life with symptoms worsening in cooler temperatures.

In his own study, Prof. Burkhardt examined the case of a previously healthy woman in her early 40s, who was an avid marathon runner. After receiving one dose of the Pfizer vaccine, the woman began to experience blood perfusion problems, sensitivity to cold temperatures and had difficulty walking.

“The angiogram (a type of X-ray to examine blood vessels) showed double barred arteries in the legs so this is the phenomenon that I described before that the media necrosis (a lesion and deterioration of the middle layer of the vessel wall), in this case, it was not in the aorta, but it was in the lower leg arteries,” he said. “This lady was fortunate, in a way, that this media necrosis (the defect that weakens the vessel) did not rupture, but it found its way back (into the vessel).”

Vessel dissection with and without rupture

The dissection of a vessel begins with the blood traveling from within the vessel into the vessel wall. It then separates the wall into two layers along a certain distance. As it does so, the blood will by chance either flow back into the vessel, or altogether out of the vessel.

If the blood flows back into the vessel, then one now has two barrels — the first being the original lumen (the space within the vessel), and the second being the newly created path through the vessel wall.

If the blood flows completely out of the vessel, then you have, in effect, a rupture — the blood can flow freely from the lumen along the dissection and then out of the vessel.

The first situation, in which the blood flows back into the vessel, is survivable even though the double barrel vessel will cause some flow resistance. But the second situation, if it happens in a large enough artery, will cause unstoppable internal hemorrhage.

(A dissection of the aorta in a twice COVID vaccinated 55 year-old man is discussed earlier in the interview and can be found here.)

---

Additionally, a biopsy of the woman’s skin was taken which showed vasculitis, necrosis of the endothelium and the presence of the spike protein.

The woman had undergone several therapeutic measures, including plasmapheresis, which is a removal of antibodies from the blood. According to Prof. Burkhardt, she has had some improvements to her health but her condition relapses.

“Not a normal thrombosis”

While several tests had already been performed on the woman, an examination of her blood sample was revealing.

The woman called Prof. Burkhardt to notify him that her doctor drew blood for analysis. After the blood sample had been centrifuged, a process in which the red blood cells, plasma and platelets are separated and cooled, an unusual clot-like structure was observed in the upper part of the vial where the serum is. 

Apparently, the structure was not thrombus because it was white and did not contain red blood cells. It also had a jelly-like and sticky texture.

Prof. Burkhardt then examined the clot under the microscope using a special staining technique which highlights fibrin. The extracellular proteins within the clot were identified with modern biochemical techniques in another laboratory.

Upon examination, he found it was almost a cell-free aggregation of small microfibrils of immature fibrin, or fibrinogen, which is the precursor protein of fibrin and is usually soluble. 

“The thing is it’s definitely not a normal thrombosis.”

Mature fibrin, which is stained red, is only observed on the surface of the clot in addition to thrombocytes, lymphocytes and CD61, which is a constituent of endothelial cells. The purple stained structures are very delicate fibers, which are likely pre-stage fibrin or fibrinogen.

“The contents of endothelial cells comes into the blood and under certain circumstances, apparently after cooling, these may form these clots.”

A proteomic analysis, which is a comprehensive identification of proteins contained in a clot, was completed by a different laboratory. The lab determined that the proteinase composition of the serum and of the clot differed. There were 139 proteinase structures in the clot that were not in the serum, including but not limited to extracellular matrix, collagen, elastin and CD31, which is related to the endothelial contents.

“We concluded that these clot formations are an indication that in the past, there was an endothelial damage and if it’s still forming, it’s an ongoing endothelial damage. And through the endothelial damage, proteins and matrix constituents of the vessel wall come into the blood and circulate in the blood. And under certain circumstances, they can form these clots.”

Continuing research

At the time of filming the interview, Prof. Burkhardt was working on several similar cases in which vaccinated persons developed a similar type of abnormal clot.

While Prof. Burkhardt said they did not have a systematic evaluation to determine if the clots and subsequent symptoms were caused by the vaccination, it appeared to have an association.

“We have one specimen which was taken from a person who was still living, and they did angioplasty (a therapeutic intervention to widen a constricted blood vessel), and they removed this type of clot outside of an artery.”

These unusual blood clots are “definitely associated with temperature,” said Prof. Burkhardt. The 40 year-old marathon runner and others with the same clot have reported a worsening of symptoms in colder temperatures, including a lack of circulation in the hands.

Moreover, in all of Prof. Burkhardt’s years working as a pathologist, he had not seen this type of clot prior to the introduction of the COVID injections.